Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Renal and hepatic function is preserved following inducible knockout of kynurenine pathway enzymes KMO or QPRT in adult mice.

PloS one·2025

Same author

"There's a lot of people who love them, so why call 'em junkies?": clinician and patient perspectives about words used to describe people who use drugs.

Addiction science & clinical practice·2025

Same author

Assessing mesh size and diffusion of alginate bioinks: A crucial factor for successful bioprinting functional pancreatic islets.

Materials today. Bio·2025

Same author

A hybrid implant combining a macroporous device with immunoprotective microcapsules for cell therapy applications: A conceptual in vitro study.

Materials today. Bio·2025

Same author

Supporting islet function in a PVDF membrane based macroencapsulation delivery device by solvent non-solvent casting using PVP.

PloS one·2025

Same author

Visualization of incrementally learned projection trajectories for longitudinal data.

Scientific reports·2024

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

Islet cell transplantation.

Vijayaganapathy Vaithilingam¹, Gayathri Sundaram, Bernard E Tuch

¹Diabetes Transplant Unit, Prince of Wales Hospital and University of New South Wales, Sydney, Australia.

Current Opinion in Organ Transplantation

|December 9, 2008

Summary

Strategies to improve islet transplantation for diabetes focus on enhancing islet mass and function. Recent advances aim to boost beta-cell survival, optimize transplantation sites, and improve islet vascularization for better patient outcomes.

More Related Videos

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

Related Experiment Videos

Last Updated: Jun 27, 2026

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

Area of Science:

Endocrinology
Transplantation Immunology
Regenerative Medicine

Background:

Human islet transplantation has evolved significantly since 1989, with steroid-free protocols improving initial insulin independence.
Despite advancements, beta-cell function declines post-transplantation, necessitating strategies to enhance islet mass and preserve function.

Purpose of the Study:

To review recent advancements in human islet transplantation.
To identify strategies for improving beta-cell mass and function post-transplantation.

Main Methods:

Review of recent literature on islet isolation, donor selection, and functional prediction.
Discussion of novel transplantation sites, biomaterial scaffolds, and beta-cell protection methods.
Exploration of islet imaging, vascularization enhancement, and encapsulation techniques.

Main Results:

Optimized enzyme selection and use of pancreases from heart-dead donors improve islet isolation.
Alternative transplantation sites and biodegradable scaffolds mitigate inflammatory destruction.
Methods to prevent beta-cell apoptosis and enhance vascularization improve graft survival and function.
Exenatide post-transplantation and islet encapsulation show beneficial effects, potentially reducing immunosuppression needs.

Conclusions:

The reviewed strategies are expected to significantly improve clinical islet transplant outcomes.
Further research into beta-cell expansion in vitro may offer future therapeutic avenues.